# Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

> **NCT00818805** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 50 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Olopatadine 0.1%
- **DRUG:** Tranilast 0.5%
- **DRUG:** Placebo (Olopatadine)
- **DRUG:** Placebo (Tranilast)

## Key facts

- **NCT ID:** NCT00818805
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818805, "Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00818805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*